Spoor Johan M.'s Form 4 filing
Perspective Therapeutics, Inc.CATX · filed Jun 13, 2024
- Accession no.
- 0000950170-24-073145
- Filed
- Jun 13, 2024
- Trade date
- Jun 13, 2024
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction. Open-market purchases total $117.0K. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Spoor Johan M.CIK 0001535289 | Director, Officer (CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 13, 2024 | Common Stock | PPurchaseAcquired | +100,000 | $1.17F1 | +$117,000 | 137,572 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The price in column 4 is a weighted average price. The prices actually paid ranged from $1.1650 to $1.1800. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or a securityholder of the issuer, full information regarding the number of shares purchased at each separate price within the range.
Referenced by the price of 1 transaction in Table I.